Table 4.
Guidelines and expert consensuses for the prophylaxis of PCP and other opportunistic infections in immunocompromised patients without HIV/AIDS.
| Countries | Release Years | Immunocompromised Conditions | References |
|---|---|---|---|
| Asia | 2021 | Systemic lupus erythematosus | [368] |
| Australia | 2014 | Haematological malignancies and stem cell transplantation | [369] |
| Europe | 2016 | Haematological malignancies and stem cell transplantation | [52] |
| Europe | 2022 | Autoimmune inflammatory rheumatic diseases | [370] |
| Europe | 2018 | Relapsed or refractory lymphocytic leukemia patients | [371] |
| Germany | 2021 | Haematopoietic stem cell transplantation, solid tumors, and autoimmune disorders | [372] |
| Japan | 2019 | Use of methotrexate in rheumatoid arthritis | [373] |
| Spain | 2022 | Autoimmune rheumatic diseases | [374] |
| UK | 2017 | Solid tumors in children | [375] |
| UK | 2020 | Anti-neutrophil cytoplasm antibody-associated vasculitis patients receiving Rituximab for maintenance | [376] |
| USA | 2019 | Solid organ transplantation | [111] |
| USA | 2018 | Cancers | [377] |